Abstract:Purpose: Bladder cancer (BCa) is a common malignancy in the urinary system. This study aims to explore the role of miR-186 in BCa tumorigenesis. Methods: The expression of miR-186 and ADAMTS12 in clinical BCa tissues and cell lines was detected. BCa cell lines T24, 5637 and EJ were used to transfect miR-186 mimics or inhibitors. Luciferase reporter gene detection confirmed the correlation between miR-186 and ADAMTS12. MTT method and flow cytometry were used to detect cell viability and apoptosis. Cell migration and invasion ability was detected by transwell assay. The protein level of ADAMTS12, β-catenin, GSK-3β and p-GSK-3β was determined using western blot analysis. Results: MiR-186 was negatively correlated with the expression of ADAMTS12 in BCa tissues. Further research confirmed that ADAMTS12 is the direct target of miR-186. In addition, overexpression of miR-186 down-regulated the expression of ADAMTS12,inhibiting cell viability and apoptosis, while knockout of miR-186 led to the opposite result. miR-186 also inhibits the phosphorylation of GSK-3 β and β-catenin without changing the total GSK-3β level. Our study shows that miR-186 has a negative regulatory effecton the expression of ADAMTS12 in clinical specimens and in vitro. miR-186 can inhibit the proliferation and invasion of BCa cells. Conclusions: miR-186 has the potential to be used as a biomarker in the early detection of BCa. Keywords: Purpose: Bladder cancer (BCa) is a common malignancy in the urinary system. This study aims to explore the role of miR-186 in BCatumorigenesis.Methods: The expression of miR-186 and ADAMTS12 in clinical BCa tissues and cell lines was detected. BCa cell lines T24, 5637 andEJ were used to transfect miR-186 mimics or inhibitors. Luciferase reporter gene detection confirmed the correlation between miR-186 and ADAMTS12. MTT method and flow cytometry were used to detect cell viability and apoptosis. Cell migration and invasionability was detected by transwell assay. The protein level of ADAMTS12, β-catenin, GSK-3β and p-GSK-3β was determined usingwestern blot analysis.Results: MiR-186 was negatively correlated with the expression of ADAMTS12 in BCa tissues. Further research confirmed thatADAMTS12 is the direct target of miR-186. In addition, overexpression of miR-186 down-regulated the expression of ADAMTS12,inhibiting cell viability and apoptosis, while knockout of miR-186 led to the opposite result. miR-186 also inhibits the phosphorylationof GSK-3 β and β-catenin without changing the total GSK-3β level. Our study shows that miR-186 has a negative regulatory effecton the expression of ADAMTS12 in clinical specimens and in vitro. miR-186 can inhibit the proliferation and invasion of BCa cells.Conclusions: miR-186 has the potential to be used as a biomarker in the early detection of BCa.Keywords: miR-186; ADAMTS12; bladder cancer; proliferation; metastasis biomarker.

Tumor-suppressing Effects of Microrna-612 in Bladder Cancer Cells by Targeting Malic Enzyme 1 Expression.

MiRNA‐516a Promotes Bladder Cancer Metastasis by Inhibiting MMP9 Protein Degradation Via the AKT/FOXO3A/SMURF1 Axis

Nonconserved Mir‐608 Suppresses Prostate Cancer Progression Through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 Pathways by Targeting the 3′‐utrs of RAC2/BCL2L1 and the Coding Region of PAK4

MicroRNA-204-3p Inhibits Metastasis of Pancreatic Cancer Via Downregulating MGAT1.

MicroRNA-186 suppresses cell proliferation and metastasis in bladder cancer

Biological Functions and Molecular Mechanisms of MiR-608 in Cancer

miR-200c Inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3

MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway

MiR-22 Suppresses Epithelial–mesenchymal Transition in Bladder Cancer by Inhibiting Snail and MAPK1/Slug/vimentin Feedback Loop

CCND1, NOP14 and DNMT3B Are Involved in Mir‐502‐5p–mediated Inhibition of Cell Migration and Proliferation in Bladder Cancer

Mir-1-3p Contributes to Cell Proliferation and Invasion by Targeting Glutaminase in Bladder Cancer Cells

MicroRNA-576-3p Inhibits Proliferation in Bladder Cancer Cells by Targeting Cyclin D1.

MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis

MicroRNA-370 suppresses SOX12 transcription and acts as a tumor suppressor in bladder cancer.

Microrna-490-5p Is A Novel Tumor Suppressor Targeting C-Fos In Human Bladder Cancer

Comprehensive Investigation of Aberrant Microrna Profiling in Bladder Cancer Tissues.

Overexpression of Mir-340 Inhibits Cell Proliferation and Induces Apoptosis of Human Bladder Cancer Via Targeting Glut-1

MicroRNA-143 As a Tumor Suppressor for Bladder Cancer.

MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met

MicroRNA-34a Inhibits Bladder Cancer Cell Migration and Invasion, and Upregulates PTEN Expression

MicroRNA-320c Inhibits Tumorous Behaviors of Bladder Cancer by Targeting Cyclin-dependent Kinase 6